| Tumors and Oncological Cases | Lifetime | 20 | DE 1 | 99.59 |
| Oral and Maxillofacial Pathology | Lifetime | 50 | DE 1 | 99.50 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 38 | DE 1 | 99.54 |
| Ear and Head Tumors | Lifetime | 24 | DE 1 | 99.48 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 51 | DE 4 | 99.58 |
| Gastrointestinal disorders and treatments | Lifetime | 88 | DE 9 | 99.51 |
| Sarcoma Diagnosis and Treatment | Lifetime | 110 | DE 5 | 99.44 |
| Soft tissue tumor case studies | Lifetime | 30 | DE 2 | 99.51 |
| Neurofibromatosis and Schwannoma Cases | Lifetime | 42 | DE 2 | 99.27 |
| Cancer Mechanisms and Therapy | Lifetime | 69 | DE 4 | 99.04 |
| Head and Neck Surgical Oncology | Lifetime | 125 | DE 3 | 99.21 |
| Cancer and Skin Lesions | Lifetime | 96 | DE 9 | 98.83 |
| Vascular Malformations and Hemangiomas | Lifetime | 54 | DE 6 | 98.53 |
| Chromatin Remodeling and Cancer | Lifetime | 38 | DE 6 | 98.70 |
| Cardiac tumors and thrombi | Lifetime | 116 | DE 5 | 98.76 |
| Renal cell carcinoma treatment | Lifetime | 281 | DE 15 | 98.65 |
| Metastasis and carcinoma case studies | Lifetime | 215 | DE 8 | 98.09 |
| Vascular Tumors and Angiosarcomas | Lifetime | 99 | DE 5 | 98.40 |
| Neuroendocrine Tumor Research Advances | Lifetime | 430 | DE 30 | 98.47 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 55 | DE 2 | 97.59 |
| Medical Imaging and Pathology Studies | Lifetime | 440 | DE 16 | 97.70 |
| Histiocytic Disorders and Treatments | Lifetime | 81 | DE 3 | 97.69 |
| Bone Tumor Diagnosis and Treatments | Lifetime | 374 | DE 13 | 97.55 |
| Renal and related cancers | Lifetime | 584 | DE 34 | 97.37 |
| Tuberous Sclerosis Complex Research | Lifetime | 75 | DE 3 | 96.35 |
| Urologic and reproductive health conditions | Lifetime | 490 | DE 36 | 96.97 |
| Soft tissue tumors and treatment | Lifetime | 96 | DE 6 | 94.12 |
| Mechanisms of cancer metastasis | Lifetime | 128 | DE 7 | 89.23 |
| Infectious Disease Case Reports and Treatments | Lifetime | 786 | DE 36 | 65.20 |
| Salivary Gland Tumors Diagnosis and Treatment | 2021-2025 | 1 | DE 1 | 99.77 |
| Ear and Head Tumors | 2021-2025 | 1 | DE 1 | 99.78 |
| Tumors and Oncological Cases | 2021-2025 | 1 | DE 1 | 99.72 |
| Head and Neck Surgical Oncology | 2021-2025 | 4 | DE 2 | 99.44 |
| Oral and Maxillofacial Pathology | 2021-2025 | 4 | DE 1 | 99.63 |
| Sarcoma Diagnosis and Treatment | 2021-2025 | 10 | DE 1 | 99.47 |
| Chromatin Remodeling and Cancer | 2021-2025 | 3 | DE 2 | 99.15 |
| Soft tissue tumor case studies | 2021-2025 | 2 | DE 1 | 99.25 |
| Cancer and Skin Lesions | 2021-2025 | 8 | DE 2 | 98.21 |
| Vascular Tumors and Angiosarcomas | 2021-2025 | 7 | DE 1 | 98.74 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 48 | DE 5 | 98.21 |
| Cancer Mechanisms and Therapy | 2021-2025 | 29 | DE 2 | 97.37 |
| Bone Tumor Diagnosis and Treatments | 2021-2025 | 29 | DE 2 | 97.45 |
| Cardiac tumors and thrombi | 2021-2025 | 28 | DE 1 | 97.24 |
| Renal cell carcinoma treatment | 2021-2025 | 135 | DE 5 | 97.56 |
| Renal and related cancers | 2021-2025 | 85 | DE 4 | 97.12 |
| Neurofibromatosis and Schwannoma Cases | 2021-2025 | 53 | DE 6 | 95.54 |
| Head and Neck Cancer Studies | 2021-2025 | 295 | DE 11 | 95.44 |
| Tuberous Sclerosis Complex Research | 2021-2025 | 27 | DE 2 | 92.57 |
| Medical Imaging and Pathology Studies | 2021-2025 | 230 | DE 13 | 88.57 |
| Peptidase Inhibition and Analysis | 2021-2025 | 826 | DE 79 | 87.42 |
| Vascular Malformations and Hemangiomas | 2021-2025 | 132 | DE 8 | 86.75 |
| Uterine Myomas and Treatments | 2021-2025 | 423 | DE 14 | 88.50 |
| Neuroblastoma Research and Treatments | 2021-2025 | 692 | DE 62 | 85.54 |
| Colorectal and Anal Carcinomas | 2021-2025 | 852 | DE 33 | 83.70 |
| Cancer Diagnosis and Treatment | 2021-2025 | 764 | DE 50 | 76.53 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 179 | DE 3 | 75.42 |
| Head and Neck Anomalies | 2021-2025 | 624 | DE 22 | 55.38 |
| Soft tissue tumors and treatment | 2021-2025 | 167 | DE 9 | 45.60 |
